{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,6]],"date-time":"2026-09-06T08:18:11Z","timestamp":1788682691415,"version":"build-2803163510"},"reference-count":41,"publisher":"Elsevier BV","issue":"19","license":[{"start":{"date-parts":[[2006,5,1]],"date-time":"2006-05-01T00:00:00Z","timestamp":1146441600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Medicina Cl\u00ednica"],"published-print":{"date-parts":[[2006,5]]},"DOI":"10.1157\/13088948","type":"journal-article","created":{"date-parts":[[2006,6,6]],"date-time":"2006-06-06T13:33:31Z","timestamp":1149600811000},"page":"744-749","source":"Crossref","is-referenced-by-count":8,"title":["Efectos secundarios potencialmente graves del tratamiento antirretroviral"],"prefix":"10.1016","volume":"126","author":[{"given":"V\u00edctor Juli\u00e1n","family":"Moreno-Cuerda","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Montserrat","family":"Morales-Conejo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rafael","family":"Rubio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1157\/13088948_bib1","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1056\/NEJM199803263381301","article-title":"Declining morbidity and mortality among patiens with advanced HIV infection","volume":"338","author":"Palella","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1157\/13088948_bib2","unstructured":"Department of Health and Human Services (DHHS). Guidelines for the use of antirretroviral agents in HIV-infected adults and adolescents. October 29, 2004. Disponible en: http:\/\/www.hivats.org"},{"key":"10.1157\/13088948_bib3","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1056\/NEJMoa012035","article-title":"Changes in mitochondrial DNA as a marker of nucleoside toxicity in HIV infected patients","volume":"346","author":"Cote","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1157\/13088948_bib4","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1038\/nm0595-417","article-title":"Mitochondrial toxicity of antiviral drugs","volume":"1","author":"Lewis","year":"1995","journal-title":"Nat Med"},{"key":"10.1157\/13088948_bib5","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1086\/339041","article-title":"Severe nucleoside-associated lactic acidosis in human immunodeficiency virus-infected patients: report of 12 cases and review","volume":"34","author":"Falc\u00f3","year":"2002","journal-title":"Clin Infect Dis"},{"key":"10.1157\/13088948_bib6","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/S0026-0495(97)90259-6","article-title":"Lactic acidosis and other mitochondrial disorders","volume":"46","author":"Stacpoole","year":"1997","journal-title":"Metabolism"},{"key":"10.1157\/13088948_bib7","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1097\/01.qai.0000137004.63376.27","article-title":"Mitochondrial dysfunction: patient monitoring and toxicity management","volume":"37","author":"McComsey","year":"2004","journal-title":"J Adquir Immune Defic Syndr"},{"key":"10.1157\/13088948_bib8","series-title":"Actas de 8th Conference on Retroviruses and Opportunisnic Infections","article-title":"Hyperlactatemia in HIV-infected patients: the role of NRTI treatment (resumen 625)","author":"Vrouenraets","year":"2001"},{"key":"10.1157\/13088948_bib9","first-page":"141","article-title":"Mitochondril toxicity of nucleoside analogue reverse transcriptase inhibitors: lactic acidosis, risk factors and therapeutic options","volume":"1","author":"Brinkman","year":"1999","journal-title":"AIDS Rev"},{"key":"10.1157\/13088948_bib10","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1086\/383151","article-title":"Nuceoside analogues and mitochondrial toxicity","volume":"38","author":"Fleischer","year":"2004","journal-title":"Clin Infect Dis"},{"key":"10.1157\/13088948_bib11","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/S0025-7753(01)72001-5","article-title":"Hiperlactatemia sintom\u00e1tica en pacientes con infecci\u00f3n por el virus de la inmunodeficiencia humana tratados con an\u00e1logos de nucle\u00f3sidos","volume":"117","author":"Lozano","year":"2001","journal-title":"Med Clin (Barc)"},{"key":"10.1157\/13088948_bib12","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1016\/S0014-2565(02)71138-7","article-title":"Hiperlactatemia sintom\u00e1tica en relaci\u00f3n con el uso de antirretrov\u00edricos","volume":"202","author":"Olalla","year":"2002","journal-title":"Rev Clin Esp"},{"key":"10.1157\/13088948_bib13","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1097\/00002030-200104130-00016","article-title":"Management of hyperlactatemia: no need for routine lactate mesurements","volume":"15","author":"Brinkman","year":"2001","journal-title":"AIDS"},{"key":"10.1157\/13088948_bib14","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1157\/13050704","article-title":"Toxicidad mitocondrial de los antirretrovirales: diagn\u00f3stico y monitorizaci\u00f3n","volume":"121","author":"Mendoza","year":"2003","journal-title":"Med Clin (Barc)"},{"key":"10.1157\/13088948_bib15","doi-asserted-by":"crossref","first-page":"2801","DOI":"10.1097\/00002030-200012010-00027","article-title":"Treatment of nucleoside reverse transcriptase inhibitor-induced lactic acidosis","volume":"14","author":"Brinkman","year":"2000","journal-title":"AIDS"},{"key":"10.1157\/13088948_bib16","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1016\/S0140-6736(99)00523-1","article-title":"Riboflavine and severe lactic acidosis","volume":"353","author":"Luzzati","year":"1999","journal-title":"Lancet"},{"key":"10.1157\/13088948_bib17","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/S0002-9343(99)00169-2","article-title":"Acute pancreatitis in human immunodeficiency virus-infected patients: a review","volume":"107","author":"Dassopoulos","year":"1999","journal-title":"Am J Med"},{"key":"10.1157\/13088948_bib18","doi-asserted-by":"crossref","first-page":"E1","DOI":"10.1097\/00006676-200307000-00016","article-title":"Acute panceatitis in HIV-infected patients: are etiologies changing since introduction of protease inhibitor therapy?","volume":"27","author":"Bush","year":"2003","journal-title":"Pancreas"},{"key":"10.1157\/13088948_bib19","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/S0025-7753(02)72288-4","article-title":"Pancreatitis, triglic\u00e9ridos y tratamiento antirretroviral de gran actividad","volume":"118","author":"Palacios","year":"2002","journal-title":"Med Clin (Barc)"},{"key":"10.1157\/13088948_bib20","doi-asserted-by":"crossref","first-page":"515","DOI":"10.2165\/00003495-199346030-00010","article-title":"Zidovudine: an update of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy","volume":"46","author":"Wilde","year":"1993","journal-title":"Drugs"},{"key":"10.1157\/13088948_bib21","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/S0149-2918(04)90009-4","article-title":"Changes in hematologic parameters and efficacy of thymidine analogue-based highly active antiretroviral therapy: a meta-analysis of six prospective, randomized, comparative studies","volume":"26","author":"Moyle","year":"2004","journal-title":"Clin Ther"},{"issue":"Suppl 1","key":"10.1157\/13088948_bib22","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/0192-0561(91)90131-P","article-title":"Experimental studies of the hematologic and immune system toxicity of the nucleoside derivates against HIV infection","volume":"13","author":"Luster","year":"1991","journal-title":"Int J Immunopharmacol"},{"key":"10.1157\/13088948_bib23","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1097\/00126334-200312010-00003","article-title":"Once week epoetin alfa dosing is as effective as three times-weekly dosing in increasing hemoglobin levels and is associated with an improved quality of life in anemic HIV-infected patients","volume":"34","author":"Grossman","year":"2003","journal-title":"J Adquir Immune Defic Syndr"},{"key":"10.1157\/13088948_bib24","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1089\/aid.2004.20.1037","article-title":"Once week epoetinalfa improves quality of life and increases haemoglobin in anemic HIVpositive patients","volume":"20","author":"Saag","year":"2004","journal-title":"AIDS Res Hum Retroviruses"},{"key":"10.1157\/13088948_bib25","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1056\/NEJM199004193221602","article-title":"Mitochondrial myopathy caused by long-term zidovudine therapy","volume":"322","author":"Dalakas","year":"1990","journal-title":"N Engl J Med"},{"key":"10.1157\/13088948_bib26","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1097\/01.aids.0000131309.70451.fe","article-title":"HIV-associated neuromuscular weakness syndrome","volume":"18","year":"2004","journal-title":"AIDS"},{"key":"10.1157\/13088948_bib27","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1016\/S0149-2918(01)80132-6","article-title":"Hipersensibility reactions during therapy with de nucleoside reverse transcriptase inhibitor abacavir","volume":"23","author":"Hetherington","year":"2001","journal-title":"Clin Ther"},{"key":"10.1157\/13088948_bib28","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1086\/339751","article-title":"Abacavir hypersensibility reaction","volume":"34","author":"Hewitt","year":"2002","journal-title":"Clin Infect Dis"},{"key":"10.1157\/13088948_bib29","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1097\/00002030-199905280-00022","article-title":"Anaphylaxis after rechallenge with abacavir","volume":"13","author":"Walensky","year":"1999","journal-title":"AIDS"},{"key":"10.1157\/13088948_bib30","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/S1089-3261(03)00023-0","article-title":"Antiretroviral-associated liver injury","volume":"7","author":"Ogedegbe","year":"2003","journal-title":"Clin Liver Dis"},{"key":"10.1157\/13088948_bib31","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1097\/00126334-200108150-00002","article-title":"Risk factors for severe hepatic injury following the introduction of HAART","volume":"27","author":"N\u00fa\u00f1ez","year":"2001","journal-title":"J Acquir Immune Def Syndr"},{"key":"10.1157\/13088948_bib32","doi-asserted-by":"crossref","first-page":"2209","DOI":"10.1097\/00002030-200310170-00009","article-title":"Cases series of acute hepatitis in a non-selected group of HIVinfected patients on nevirapine-containing antiretroviral treatment","volume":"17","author":"De Maat","year":"2003","journal-title":"AIDS"},{"key":"10.1157\/13088948_bib33","doi-asserted-by":"crossref","first-page":"53","DOI":"10.2165\/00002018-200528010-00004","article-title":"Hepatotoxicity of antiretrovirals: incidente, mechanisms and management","volume":"28","author":"Nu\u00f1ez","year":"2005","journal-title":"Drug Saf"},{"key":"10.1157\/13088948_bib34","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1517\/13543784.5.9.1183","article-title":"Nevirapina: a review of its development, pharmacological profile and potencial for clinical use","volume":"5","author":"Murphy","year":"1996","journal-title":"Exp Opin Invest Drugs"},{"key":"10.1157\/13088948_bib35","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1310\/3Q91-YT2D-BUT4-8HN6","article-title":"Safety and tolerante of efavirenz in different antiretroviral regimenes: results from a nacional multicenter prospective study in 1033 HIV-infected patients","volume":"3","author":"P\u00e9rez Molina","year":"2002","journal-title":"HIV Clin Trials"},{"key":"10.1157\/13088948_bib36","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1046\/j.1365-2516.2000.00420.x","article-title":"Protease inhibitor therapy and bleeding","volume":"6","author":"Wilde","year":"2000","journal-title":"Haemophilia"},{"key":"10.1157\/13088948_bib37","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1016\/S0022-5347(01)61595-7","article-title":"Frequency of urolithiasis in individuals seropositive for human immunodeficiency virus treated with indinavir is higher than previously assumed","volume":"161","author":"Reiter","year":"1999","journal-title":"J Urol"},{"key":"10.1157\/13088948_bib38","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1086\/339486","article-title":"Indinavir associated interstitial nephritis and urothelial inflammation: clinical and cytologic findings","volume":"99","author":"Kopp","year":"2002","journal-title":"Clin Infect Dis"},{"key":"10.1157\/13088948_bib39","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1053\/ajkd.2002.36924","article-title":"Fanconi syndrome and renal failure induced by tenofovir: a first case report","volume":"40","author":"Verhelst","year":"2002","journal-title":"Am J Kidney Dis"},{"key":"10.1157\/13088948_bib40","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1086\/368314","article-title":"Tenofovir-related nephrotoxicity in human immunodeficiency virus-infected patients. Three cases of renal failure, Fanconi syndrome and nephogenic diabetes insipidus","volume":"36","author":"Karras","year":"2003","journal-title":"Clin Infect Dis"},{"key":"10.1157\/13088948_bib41","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1097\/00126334-200403010-00007","article-title":"Renal tubular dysfunction associated with tenofovir therapy. Report of 7 cases","volume":"35","author":"Peyriere","year":"2004","journal-title":"J Acquir Immune Defic Syndr"}],"container-title":["Medicina Cl\u00ednica"],"original-title":[],"language":"es","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025775306720784?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025775306720784?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,1,16]],"date-time":"2019-01-16T03:50:16Z","timestamp":1547610616000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0025775306720784"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,5]]},"references-count":41,"journal-issue":{"issue":"19","published-print":{"date-parts":[[2006,5]]}},"alternative-id":["S0025775306720784"],"URL":"https:\/\/doi.org\/10.1157\/13088948","relation":{},"ISSN":["0025-7753"],"issn-type":[{"value":"0025-7753","type":"print"}],"subject":[],"published":{"date-parts":[[2006,5]]}}}